IntraBio is a biotechnology company focused on discovering, developing, and commercializing novel therapies for rare and neurodegenerative diseases with high unmet medical needs. The company emphasizes lead programs and mechanism of action insights to advance therapeutics through research and clinical development. Its activities span from drug discovery and translational science to clinical trials and publications, aiming to bring targeted treatments to patients with limited options. The organization positions itself as a leader in rare disease therapeutics, with progress and collaborations highlighted on its website.
No recent deals for this company.